ReNeuroGen LLC

Elm Grove, United States · Founded 2018 · $686K raised

Employees
1–10
Founded
2018
Business Model
B2B
Website
rngen.com
Total Funding
$686K
Last Round
$100K GrantDec 2025
Rounds
3

About

ReNeuroGen LLC is a virtual pharmaceutical company developing systems pharmacology therapies for neurological and pulmonary diseases. Its lead candidate, KYC (N-acetyl-lysyltyrosylcysteine amide), is a tripeptide myeloperoxidase inhibitor being evaluated for Sickle Cell Disease, Multiple Sclerosis, traumatic brain injury, and bronchopulmonary dysplasia. The company is NIH-funded and collaborates with the Medical College of Wisconsin.

Summary

ReNeuroGen LLC is a Biotech company based in Elm Grove, United States, founded in 2018. It has raised $686K in total across 3 rounds, most recently a $100K Grant round in Dec 2025. Investors include National Institutes of Health.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantDec 2025
$100K

Sign up to see all 3 rounds

Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ReNeuroGen LLC on Indexed.vc
<a href="https://indexed.vc/companies/reneurogen-llc"><img src="https://indexed.vc/api/badge/company/reneurogen-llc" alt="ReNeuroGen LLC on Indexed.vc" width="260" height="76" /></a>